Content area
Full Text
[Image omitted] - Moncef Slaoui, GlaxoSmithKline ($GSK)
2012 pay package: $4.61 million
2011 pay package: $4.89 million
Change: -5.72%
2012 Compensation: $1.15 million in salary; $1.40 million in bonus; $1.69 million in performance shares; $363,000 in other benefits
Dr. Moncef Slaoui took over as chairman of R&D in 2006, but his biggest task didn't begin until after CEO Andrew Witty stepped up in 2008. Since then, Slaoui has thrown out the company's R&D procedures and reorganized the research division into 38 smaller--and theoretically more nimble--individual units.
Last year wasn't a banner year, certainly, with a few new-drug approvals and a handful of new indications for existing meds. But...